Looking to expand your partner network with the latest in the field of chemotherapy? Consider joining Inpart's global network for free.
In Depth 9 Jul 2025
New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage?
Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval.